Reduced pro-inflammatory dendritic cell phenotypes are a potential indicator of successful peanut oral immunotherapy

HIGHLIGHTS

• who: Sara Anvari and collaborators from the Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, United States of America, Department of Pediatrics, Vagelos College of Physicians and Surgeons Columbia University have published the article: Reduced pro-inflammatory dendritic cell phenotypes are a potential indicator of successful peanut oral immunotherapy, in the Journal: PLOS ONE of 24/08/2020
• what: For this work, the authors investigated myeloid DCs (mDCs) and plasmacytoid DCs (pDCs), both known to have antigen-presenting capabilities. The authors demonstrate the influence of POIT on DCs to promote desensitization . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.